2021 Hematology and Medical Oncology Best Practices Course - On Demand
This course features Up to 70 hours of comprehensive, exam-focused content, patterned after the hematology and medical oncology ABIM Blueprint.
- Up to 70 hours of comprehensive, exam-focused content, patterned after the hematology and medical oncology ABIM Blueprint
- 1-year access to high quality video presentations featuring the nation's leading clinician-educators (streaming media and downloadable audio)
- All content can be conveniently accessed from any computer, mobile device, or smartphone
- Practice exam with 200+ questions
- Access to the course electronic syllabus
- Up to 70.25 CME credits and MOC points
This course is ideal for physicians preparing to take the Hematology and Medical Oncology certification exams as well as individuals desiring a comprehensive review of hematology and medical oncology standards of care.
At the conclusion of the Hematology and Medical Oncology Best Practices course, the successful learner will be able to:
- understand red cell disorders;
- understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies;
- understand blood and marrow morphology and hematopathology;
- understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors.
- be familiar with the diagnosis, evaluation, and management of hematologic malignancies;
- understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs; and
- identify strategies for taking the board examinations.
- understand the epidemiology of malignant diseases and management of the medical complications of malignancy;
- recognize the latest advances in cancers of the lung, the breast, and the gastrointestinal tract;
- understand the principles of management of gynecologic and other genito-urinary malignancies;
- contend with complexity of HIV related malignancies;
- recognize principles of new developments in biologic therapy of cancer.
- Session 1: Anemias, Bone Marrow Failure, and Sickle Cell Disease
- Session 2: WBC Disorders and Coagulopathy
- Session 3: Thrombocytopenias, Anemias and Myeloproliferative Disease
- Session 1: Lymphomas, CLL, ALL, CML, Plasma Cell Disorders, and MDS
- Session 2: AML, Pharmacology, and BMT
- Session 1: Breast Cancer, Lung Cancer, and Neuro-Oncology
- Session 2: GU, GYN and GI Tumors
- Session 3: GI, Sarcoma, and Palliative Care
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician CME Credit
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 70.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 72.00 ABIM MOC 2
- 72.00 AMA PRA Category 1 Credit™The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 72.00 Completion